Proliferative glomerulonephritis with monoclonal IgG2κ deposit successfully treated with steroids: a case report and review of the literature
- PMID: 28509293
- PMCID: PMC5411552
- DOI: 10.1007/s13730-013-0064-3
Proliferative glomerulonephritis with monoclonal IgG2κ deposit successfully treated with steroids: a case report and review of the literature
Abstract
A novel form of glomerular injury with monoclonal immunoglobulin (Ig) IgG deposition, termed "proliferative glomerulonephritis (GN) with monoclonal IgG deposits" (PGNMID), is a recently described entity. PGNMID presents with various histological patterns, such as membranoproliferative GN, endocapillary proliferative GN and membranous nephropathy (MN). The deposits are composed of monoclonal immunoglobulin, most commonly IgG3 and occasionally IgG2. At present, the clinical significance of each IgG subclass and the morphological patterns of glomerular injury have not been fully investigated due to the limited number of PGNMID cases reported. The patient was a 27-year-old woman presenting with a mild degree of proteinuria and no other physical or serological abnormalities. Monoclonal Ig could not be identified in her serum or urine. Renal biopsy found features of MN with deposition of monoclonal IgG2κ. Electron microscopy examination revealed non-organised electron-dense deposits predominantly in subepithelial locations. Based on a diagnosis of PGNMID, she was treated with prednisolone and proteinuria significantly decreased in less than 4 weeks. Although the clinical outcomes of PGNMID remain to be defined, MN features may possibly be a sign of favourable prognosis-a hypothesis supported by recent reports. The absence of advanced chronic damage in the kidney, such as glomerulosclerosis or tubulointerstitial fibrosis, may also have contributed to the favourable outcome in the present case. Further studies on additional PGNMID cases that allow the correlation of morphological features and IgG subclasses with clinical outcomes are needed in order to confirm our findings and further solidify the clinical aspects of this new disease entity.
Keywords: Membranous nephropathy; Monoclonal IgG; Proliferative glomerulonephritis; Steroid.
Figures



Similar articles
-
A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report.BMC Nephrol. 2022 Dec 9;23(1):396. doi: 10.1186/s12882-022-03029-6. BMC Nephrol. 2022. PMID: 36494791 Free PMC article.
-
Discordance of light chain isotypes between serum and glomerular deposits in proliferative glomerulonephritis with monoclonal IgG deposits: a case report and review of the literature.BMC Nephrol. 2023 Jul 1;24(1):199. doi: 10.1186/s12882-023-03256-5. BMC Nephrol. 2023. PMID: 37393252 Free PMC article. Review.
-
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.Nephrology (Carlton). 2016 Jul;21 Suppl 1:48-52. doi: 10.1111/nep.12775. Nephrology (Carlton). 2016. PMID: 26971743 Review.
-
Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.BMC Nephrol. 2017 Apr 6;18(1):127. doi: 10.1186/s12882-017-0524-7. BMC Nephrol. 2017. PMID: 28385149 Free PMC article.
-
A Case of Proliferative Glomerulonephritis with Monoclonal IgG Deposits That Showed Predominantly Membranous Features.Case Rep Nephrol. 2017;2017:1027376. doi: 10.1155/2017/1027376. Epub 2017 Oct 25. Case Rep Nephrol. 2017. PMID: 29209544 Free PMC article.
Cited by
-
A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report.BMC Nephrol. 2022 Dec 9;23(1):396. doi: 10.1186/s12882-022-03029-6. BMC Nephrol. 2022. PMID: 36494791 Free PMC article.
-
Proliferative glomerulonephritis associated with monoclonal immune deposits: A case report and review of literature.Indian J Nephrol. 2014 Nov;24(6):376-9. doi: 10.4103/0971-4065.133012. Indian J Nephrol. 2014. PMID: 25484532 Free PMC article.
-
Steroid-sensitive recurrent mesangial proliferative glomerulonephritis with monoclonal IgG deposits.CEN Case Rep. 2021 May;10(2):308-313. doi: 10.1007/s13730-020-00562-x. Epub 2021 Jan 4. CEN Case Rep. 2021. PMID: 33398782 Free PMC article.
-
Discordance of light chain isotypes between serum and glomerular deposits in proliferative glomerulonephritis with monoclonal IgG deposits: a case report and review of the literature.BMC Nephrol. 2023 Jul 1;24(1):199. doi: 10.1186/s12882-023-03256-5. BMC Nephrol. 2023. PMID: 37393252 Free PMC article. Review.
-
Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximab.Clin Kidney J. 2017 Jun;10(3):405-410. doi: 10.1093/ckj/sfx001. Epub 2017 Mar 22. Clin Kidney J. 2017. PMID: 28616219 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources